🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

BioNTech SE

BNTX Healthcare
$95.95 +$2.51 (2.69%)
Market Cap: $24.26 B
Gurus Holding
2
Popularity Rank
#3920
% of Shares Held
0.05%
Net Activity (Q1 2026)
+$11.09 M

Guru Ownership Trend

Guru Analysis for BioNTech SE (BNTX)

BioNTech SE (BNTX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $13.01 M.

Top institutional holders include Catherine Wood and Paul Tudor Jones.

Institutional sentiment is currently Bullish. This is evidenced by a $11.09 M net inflow during the quarter.

Recent activity highlights Paul Tudor Jones who increased their stake by 162.4%.

Key Holders

Top 5 by Value

$11.37 M
$689,531

Top 5 by Conviction

Recent Activity Breakdown (Q1 2026)

+$11.79 M
Total Buy Value
New Buys 1
Additions 1
-$707,050
Total Sell Value
Reductions 0
Sold Out 2

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
2
Net Buyers
2

FAQs for BioNTech SE (BNTX)

Major holders include Catherine Wood ($11.37 M), Paul Tudor Jones ($689,531). According to the latest reported data, 2 tracked investment managers collectively hold approximately 135,636 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $11.09 M, with 2 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 0 managers trimmed their positions, while 2 fully exited BNTX. The total reported sell value was $707,050.

Yes, 1 managers opened new positions in BNTX, and 1 increased their existing holdings. The total reported buy value was $11.79 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.09% New Buy 127,878 $11.37 M Q1 2026
0.00% Add 162.4% 7,758 $689,531 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form